Furthermore, Belcaid et al. reported that activation of the costimulatory signal 4-1BB, in combination with CTLA-4 blockade and focal radiotherapy, improved survival in a glioma mouse model in a CD4+ T cell-dependent manner [224]. Here, CD4 is linked to central nervous system cancer.